Check out this week's QuadCast as we highlight major findings from ASCO 2024! Learn about immunotherapy neoadjuvantly for Stage III melanoma, the role of osimertinib in localized NSCLC, the role of short vs. long course ADT in salvage prostate treatment, and much more.
Check out this week's QuadCast as we highlight major findings from ASCO 2024! Learn about immunotherapy neoadjuvantly for Stage III melanoma, the role of osimertinib in localized NSCLC, the role of short vs. long course ADT in salvage prostate treatment, and much more.